|
|
Article: Research and Markets: Russia Pharmaceuticals and Healthcare Market Expected to Reach a Value of US$23.4bn by the End of 2013 Says Q3 2009 Report.(Report)
- Article from:
- Business Wire
- Article date:
- August 14, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/83b1b1/russia_pharmaceuti) has announced the addition of the "Russia Pharmaceuticals and Healthcare Report Q3 2009" report to their offering.
The Russia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Russia's pharmaceuticals and healthcare industry.
Russia's overall macroeconomic situation has stabilised markedly since the end of Q109 - most notably as the ruble's managed devaluation ...